IL10 and cutaneous leishmaniasis: A clear dichotomy between Th1-mediated protection (mediated by major cytokines IFNγ, IL-2, TNF) and Th2-mediated disease progression (mediated by major cytokines IL-10, IL-4) has been demonstrated in mice against cutaneous leishmaniasis [21, 32].